MCC950

Item no.	M6164-50mg
Manufacturer	AbMole
CASRN	210826-40-7
Amount	50mg
Category	Oncology Neuroscience Metabolism Diabetes Glucose Homeostasis Aging & Neurological Disorders Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Bone Cancer
Type	Inhibitors
Specific against	other
Purity	0,9974
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CP-456773
Available
Target Information	NLR
Molecular Weight	404, 48
Solubility	28 mg/mL in DMSO
Bioactivity information	MCC950 (CP-456773) is a potent, selective NLRP3 inhibitor with IC50 of 7.5 nM and 8.1 nM in BMDMs and HMDMs, respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M6164-50mg-safety-datasheet.pdf